At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
DOT Diary Longitudinal Pilot: A Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men
In Brief
A Phase 4 clinical trial evaluating Emtricitabine / Tenofovir Disoproxil Oral Tablet and DOT Diary mobile app for Adherence, Medication and 3 related conditions. Completed, enrolled 100 participants across 2 sites.
Detailed Summary
The researchers are working with a technology company, AiCure, to develop a smartphone app, DOT Diary, which combines two drug adherence strategies. DOT Diary reminds people when it is time to take their medication, and uses motion-sensing technology to visually and automatically confirm the pill was swallowed. The goal of this study is to assess the impact of the app on adherence to HIV pre-exposure prophylaxis (PrEP) for the prevention of HIV.
Study Details
Timeline
Interventions
Open label daily emtricitabine/tenofovir disoproxil oral tablet
DOT Diary mobile application for tracking medication adherence and sexual activities.